Patent · US Expired

IL-23p40 specific immunoglobulin derived proteins

US7252971B2 · kind B2 · utility

46Cited by
7References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2005
Grant dateAug 7, 2007
Priority date
Expiry dateSep 23, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/34
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An anti-IL-23 specific human Ig derived protein is useful in therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably includes one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.